[go: up one dir, main page]

SI3548006T1 - Sestava za uporabo pri zdravljenju črevesnih sprememb - Google Patents

Sestava za uporabo pri zdravljenju črevesnih sprememb

Info

Publication number
SI3548006T1
SI3548006T1 SI201731468T SI201731468T SI3548006T1 SI 3548006 T1 SI3548006 T1 SI 3548006T1 SI 201731468 T SI201731468 T SI 201731468T SI 201731468 T SI201731468 T SI 201731468T SI 3548006 T1 SI3548006 T1 SI 3548006T1
Authority
SI
Slovenia
Prior art keywords
treatment
composition
intestinal
alterations
intestinal alterations
Prior art date
Application number
SI201731468T
Other languages
English (en)
Inventor
Andrea Biffi
Ruggero Rossi
Walter Fiore
Silvia Salamina
Original Assignee
Alfasigma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfasigma S.P.A. filed Critical Alfasigma S.P.A.
Publication of SI3548006T1 publication Critical patent/SI3548006T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI201731468T 2016-12-01 2017-12-01 Sestava za uporabo pri zdravljenju črevesnih sprememb SI3548006T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102016000122310A IT201600122310A1 (it) 2016-12-01 2016-12-01 Composizione per uso nella terapia di alterazioni dell'intestino
PCT/IB2017/057580 WO2018100551A1 (en) 2016-12-01 2017-12-01 Composition for use in the treatment of intestinal alterations
EP17822783.1A EP3548006B1 (en) 2016-12-01 2017-12-01 Composition for use in the treatment of intestinal alterations

Publications (1)

Publication Number Publication Date
SI3548006T1 true SI3548006T1 (sl) 2024-02-29

Family

ID=58455455

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201731468T SI3548006T1 (sl) 2016-12-01 2017-12-01 Sestava za uporabo pri zdravljenju črevesnih sprememb

Country Status (21)

Country Link
US (2) US10881703B2 (sl)
EP (1) EP3548006B1 (sl)
JP (1) JP7321935B2 (sl)
KR (1) KR102508323B1 (sl)
CN (1) CN110430870B (sl)
AU (1) AU2017368931B2 (sl)
BR (1) BR112019011007A2 (sl)
CA (1) CA3045267A1 (sl)
DK (1) DK3548006T3 (sl)
ES (1) ES2968428T3 (sl)
FI (1) FI3548006T3 (sl)
HR (1) HRP20231691T1 (sl)
HU (1) HUE065202T2 (sl)
IT (1) IT201600122310A1 (sl)
LT (1) LT3548006T (sl)
PL (1) PL3548006T3 (sl)
PT (1) PT3548006T (sl)
RS (1) RS65009B1 (sl)
SI (1) SI3548006T1 (sl)
SM (1) SMT202400007T1 (sl)
WO (1) WO2018100551A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900008394A1 (it) * 2019-06-07 2020-12-07 Sofar Spa Composizione per uso nel trattamento delle malattie infiammatorie croniche intestinali
JP2021045103A (ja) * 2019-09-20 2021-03-25 国立大学法人秋田大学 貪食能測定方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739394D1 (de) * 1996-10-16 2009-06-18 Napo Pharmaceuticals Inc Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe
US20020054924A1 (en) * 2000-04-13 2002-05-09 Leahy Margaret M. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
MX2008005932A (es) * 2005-11-07 2008-12-17 Perque Llc Composiciones para regular trastornos intestinales y metodos de uso de las mismas.
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
DE202010008308U1 (de) * 2010-08-18 2010-10-21 Rittinghausen, Reiner, Dr. Zusammensetzung zur nutritiven Ergänzung oder Behandlung bei Harnwegsinfekten und/oder bakteriellen Entzündungen der Schleimhäute
ITMI20110409A1 (it) * 2011-03-15 2012-09-16 Velleja Res Srl Impiego delle proantocianidine di tipo a2 in forma gastroprotetta per il trattamento della cistiti in fase acuta sostenute da forme batteriche fimbriate
JP2015531770A (ja) * 2012-08-29 2015-11-05 サリックス ファーマシューティカルズ,インコーポレイテッド 緩下剤組成物、ならびに便秘および関連胃腸疾患および症状を処置するための方法
CN102823875A (zh) * 2012-09-10 2012-12-19 湖北强森魔芋科技有限公司 一种高膳食纤维代餐粉及其制备方法
KR20150103012A (ko) * 2012-11-26 2015-09-09 토마스 줄리어스 보로디 분변 마이크로바이오타 복원을 위한 조성물 및 이의 제조 및 사용 방법
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.

Also Published As

Publication number Publication date
US10881703B2 (en) 2021-01-05
EP3548006B1 (en) 2023-11-15
CN110430870A (zh) 2019-11-08
LT3548006T (lt) 2024-01-10
BR112019011007A2 (pt) 2019-10-08
WO2018100551A1 (en) 2018-06-07
AU2017368931B2 (en) 2022-12-22
RU2019120187A3 (sl) 2021-02-19
HUE065202T2 (hu) 2024-05-28
US20210077558A1 (en) 2021-03-18
CN110430870B (zh) 2023-05-23
DK3548006T3 (da) 2024-01-02
RS65009B1 (sr) 2024-01-31
JP7321935B2 (ja) 2023-08-07
US20200061141A1 (en) 2020-02-27
ES2968428T3 (es) 2024-05-09
KR102508323B1 (ko) 2023-03-08
FI3548006T3 (fi) 2023-12-19
PL3548006T3 (pl) 2024-04-29
AU2017368931A1 (en) 2019-07-04
US11690889B2 (en) 2023-07-04
SMT202400007T1 (it) 2024-03-13
EP3548006A1 (en) 2019-10-09
JP2020500934A (ja) 2020-01-16
PT3548006T (pt) 2024-01-16
HRP20231691T1 (hr) 2024-03-15
CA3045267A1 (en) 2018-06-07
KR20190111913A (ko) 2019-10-02
RU2019120187A (ru) 2021-01-11
IT201600122310A1 (it) 2018-06-01

Similar Documents

Publication Publication Date Title
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
ZA201803742B (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
IL276733A (en) Use of Aribolin in cancer treatment
IL251371A0 (en) Cortexolone 17alpha-benzoate for use in the treatment of tumors
GB201400442D0 (en) Compositions for use in the treatment of ulcerative colitis
IL248767B (en) Trimethoxyphenyl-benzaimidazole compounds for cancer treatment
PL3496733T3 (pl) Kompozycja do stosowania w leczeniu dużego zaburzenia depresyjnego
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
HUE054065T2 (hu) Szerek glióma kezelésében történõ alkalmazásra
PL3283064T3 (pl) Pochodne do zastosowania w atrofii mięśni
IL246587A0 (en) Preparations for use in the treatment of allergic conditions
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
SI3548006T1 (sl) Sestava za uporabo pri zdravljenju črevesnih sprememb
IL269121A (en) Usl-311 for use in the treatment of cancer
IL252493B (en) Compounds for use in the prevention or treatment of cancer
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
ZA201403006B (en) Composition for use in treatment of cancer
GB201511772D0 (en) Improvements in the treatment of ash